NPI: 1376931154 · SUMTER, SC 29150 · End-Stage Renal Disease (ESRD) Treatment Clinic/Center · NPI assigned 01/02/2015
Authorized official WEY, SAMUEL controls 20+ related entities in our dataset. Read more
| Authorized Official | WEY, SAMUEL (VP LICENSURE&CERTIFICATION) |
| NPI Enumeration Date | 01/02/2015 |
Other providers sharing the same authorized official: WEY, SAMUEL
| Provider | City | State | Total Paid |
|---|---|---|---|
| DVA HEALTHCARE RENAL CARE INC | NORTH HOLLYWOOD | CA | $16.47M |
| DVA HEALTHCARE RENAL CARE INC | DELANO | CA | $16.43M |
| DVA RENAL HEALTHCARE INC | LOS ANGELES | CA | $15.51M |
| DVA RENAL HEALTHCARE INC | SAN DIEGO | CA | $14.93M |
| DVA RENAL HEALTHCARE INC | SAN DIEGO | CA | $13.67M |
| DVA RENAL HEALTHCARE INC | OAKLAND | CA | $13.42M |
| DVA RENAL HEALTHCARE INC | SAN DIEGO | CA | $13.25M |
| DVA HEALTHCARE RENAL CARE INC | YUMA | AZ | $12.88M |
| DVA HEALTHCARE RENAL CARE INC | BAKERSFIELD | CA | $12.77M |
| DVA RENAL HEALTHCARE INC | FULLERTON | CA | $12.19M |
| DVA HEALTHCARE RENAL CARE INC | POMONA | CA | $11.96M |
| DVA RENAL HEALTHCARE INC | ANAHEIM | CA | $11.32M |
| DVA RENAL HEALTHCARE INC | ESCONDIDO | CA | $10.94M |
| DVA HEALTHCARE RENAL CARE INC | COSTA MESA | CA | $10.08M |
| DVA HEALTHCARE RENAL CARE INC | INGLEWOOD | CA | $9.46M |
| DVA RENAL HEALTHCARE INC | VISALIA | CA | $9.22M |
| DVA RENAL HEALTHCARE INC | SAN DIEGO | CA | $8.83M |
| DVA HEALTHCARE RENAL CARE INC | BAKERSFIELD | CA | $8.56M |
| DVA HEALTHCARE RENAL CARE INC | INGLEWOOD | CA | $7.78M |
| DVA RENAL HEALTHCARE INC | PALM SPRINGS | CA | $7.48M |
| Year | Claims | Total Paid |
|---|---|---|
| 2018 | 2,411 | $55K |
| 2019 | 6,604 | $41K |
| 2020 | 9,171 | $82K |
| 2021 | 6,223 | $62K |
| 2022 | 2,288 | $33K |
| 2023 | 888 | $13K |
| 2024 | 684 | $11K |
| Code | Description | Claims | Beneficiaries | Total Paid |
|---|---|---|---|---|
| 90935 | Hemodialysis procedure with single evaluation by a physician | 14,592 | 1,472 | $233K |
| Q4081 | Injection, epoetin alfa, 100 units (for esrd on dialysis) | 3,276 | 569 | $36K |
| A4657 | Syringe, with or without needle, each | 1,469 | 872 | $14K |
| 90674 | 32 | 31 | $9K | |
| J1756 | Injection, iron sucrose, 1 mg | 1,325 | 414 | $3K |
| J1270 | Injection, doxercalciferol, 1 mcg | 5,193 | 617 | $1K |
| 83970 | 273 | 243 | $231.41 | |
| 83550 | 221 | 193 | $75.14 | |
| 82728 | 200 | 179 | $73.81 | |
| 85048 | 589 | 522 | $66.78 | |
| 85041 | 589 | 522 | $66.31 | |
| 83540 | 222 | 193 | $65.46 | |
| G0499 | Hepatitis b screening in non-pregnant, high risk individual includes hepatitis b surface antigen (hbsag), antibodies to hbsag (anti-hbs) and antibodies to hepatitis b core antigen (anti-hbc), and is followed by a neutralizing confirmatory test, when performed, only for an initially reactive hbsag result | 142 | 87 | $64.47 |
| 82306 | Vitamin D; 25 hydroxy, includes fraction(s), if performed | 54 | 49 | $38.37 |
| 86706 | 14 | 12 | $4.25 | |
| 87340 | 16 | 13 | $3.81 | |
| 85045 | 27 | 26 | $3.47 | |
| G0008 | Administration of influenza virus vaccine | 18 | 17 | $0.00 |
| G0009 | Administration of pneumococcal vaccine | 17 | 15 | $0.00 |